Mohawk Industries (MHK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Apr, 2026Executive summary
Annual Meeting scheduled for May 21, 2026, to elect three Class I directors, ratify KPMG LLP as auditor, hold a say-on-pay vote, approve a new 2026 Incentive Plan, and consider a shareholder proposal on majority voting.
2025 sales reached $10.8B with adjusted EBITDA of $1.3B and free cash flow of $616M; net sales decreased 0.5% from 2024, with continued market challenges impacting volumes and profitability.
The company advanced operational improvements, product innovation, and sustainability initiatives to position for future growth.
Voting matters and shareholder proposals
Proposals include election of three Class I directors, ratification of KPMG LLP, advisory approval of executive compensation, approval of the 2026 Incentive Plan, and a shareholder proposal to adopt a majority vote standard.
The Board recommends voting FOR all management proposals and AGAINST the shareholder proposal on majority voting.
Board of directors and corporate governance
Board consists of nine directors in three staggered classes, with a classified board structure to promote stability and long-term focus.
Two-thirds of directors are independent; a Lead Independent Director role enhances oversight.
Board committees include Audit, Compensation, and Nominating & Corporate Governance, all composed of independent directors.
Annual board and committee self-evaluations and a robust nomination process are in place.
Stockholder engagement is emphasized, with regular outreach and communication channels.
Latest events from Mohawk Industries
- Q2 2026 delivered strong sales, margin gains, and EPS growth, aided by tariff refunds and cost actions.MHK
Q2 2026 - Q1 2026 net sales up 8% to $2.73B, adjusted EPS $1.90, net earnings $117M.MHK
Q1 2026 - Q4 2025 net sales rose 2.4% with strong cash flow; 2026 outlook expects improved earnings.MHK
Q4 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 2025 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 2024 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 2024 - Q1 2025 sales and earnings fell, but cost actions and restructuring support future improvement.MHK
Q1 2025 - Adjusted EPS steady at $1.95 as restructuring offsets weak demand; $285M savings targeted.MHK
Q4 2024